{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:09:57Z","timestamp":1769116197212,"version":"3.49.0"},"publisher-location":"Chichester, UK","reference-count":54,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000119.pub3","type":"reference-entry","created":{"date-parts":[[2008,6,30]],"date-time":"2008-06-30T11:24:52Z","timestamp":1214825092000},"source":"Crossref","is-referenced-by-count":29,"title":["Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke"],"prefix":"10.1002","author":[{"given":"Peter AG","family":"Sandercock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Counsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Chiun","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,16]]},"reference":[{"key":"10.1002\/14651858.CD000119.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ageing\/23.6.512","article-title":"A multi-centre double blind randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke","volume":"23","author":"Dumas","year":"1994","journal-title":"Age and Ageing"},{"key":"10.1002\/14651858.CD000119.pub3-BIB2|cit2","unstructured":"Hageluken C Egberts J Stiekema J A multi-centre, assessor-blind, randomised, safety study of Org 10172, administered subcutaneously twice daily, for the prophylaxis of deep vein thrombosis in patients with a non-haemorrhagic stroke of recent onset (protocol 87038) Organon International B.V. (Internal report SDGRR No. 3165), Oss, The Netherlands 1992"},{"key":"10.1002\/14651858.CD000119.pub3-BIB3|cit3","unstructured":"Hageluken C Egberts J A multi-centre, assessor-blind, randomised pilot study of three different doses of Org 10172 (375, 750 and 1250U), administered subcutaneously once daily, compared with low dose heparin, administered subcutaneously twice daily, in the prophylaxis of deep vein thrombosis (DVT) in patients with a non-haemorrhagic stroke of recent onset (protocol 85144) Organon International B.V. (Internal report SDGRR No. 3158). Oss, the Netherlands 1992"},{"key":"10.1002\/14651858.CD000119.pub3-BIB4|cit4","first-page":"S110","article-title":"Enoxaparin, a low-molecular-weight heparin (LWMH) may be superior to standard heparin in the prevention of deep-vein thrombosis (DVT) in stroke patients","volume":"5 Suppl 3","author":"Hillbom","year":"1998","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000119.pub3-BIB5|cit5","series-title":"Proceedings of the 17th Congress of the International Society on Thrombosis and Haemostasis; 1999 August 14-21; Washington, DC, USA","article-title":"Enoxaparin, a low molecular weight heparin, is superior to heparin in the prevention of deep vein thrombosis in patients with acute atherosclerotic stroke","author":"Hillbom","year":"1999"},{"key":"10.1002\/14651858.CD000119.pub3-BIB6|cit6","first-page":"183a","article-title":"Comparison of the efficacy and safety of the low-molecular-weight heparin enoxaparin with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischaemic stroke","volume":"94 Suppl 1","author":"Hillbom","year":"1999","journal-title":"Blood"},{"key":"10.1002\/14651858.CD000119.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1600-0404.2002.01215.x","article-title":"Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study","volume":"106","author":"Hillbom","year":"2002","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD000119.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(07)60633-3","article-title":"The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison","volume":"369","author":"Sherman","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000119.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.STR.0000195182.67656.ee","article-title":"Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin. Results of the PROTECT Trial","volume":"37","author":"Diener","year":"2006","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000119.pub3-BIB10|cit10","first-page":"54","article-title":"Prophylaxis of deep vein thrombosis in acute stroke. A prospective, randomised double-blind study","volume":"16 Suppl 5","author":"Hossman","year":"1986","journal-title":"Haemostasis"},{"key":"10.1002\/14651858.CD000119.pub3-BIB11|cit11","unstructured":"Stiekema JCJ Egberts JFM Voerman J An open, randomised, pilot multi-centre study of Org 10172 versus heparin administered for the purpose of deep vein thrombosis prophylaxis in patients with a non-haemorrhagic stroke of recent onset Organon International B.V. (Internal report SDGRR No. 2310). Oss, The Netherlands 1988"},{"key":"10.1002\/14651858.CD000119.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1160\/TH03-11-0680","article-title":"Treatment with anticoagulants in cerebral events (TRACE)","volume":"91","author":"Woessner","year":"2004","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD000119.pub3-BIB13|cit13","unstructured":"Magnani HN Egberts JFM A preliminary report of a multi-centre, assessor-blind, randomised, comparative safety and efficacy study of Org 10172 versus low dose heparin, administered subcutaneously twice daily for the prophylaxis of deep vein thrombosis in patients with acute thrombotic stroke (protocol 004-010) Organon International B.V (Internal report SDGRR No.3172). Oss, the Netherlands 1992"},{"key":"10.1002\/14651858.CD000119.pub3-BIB16|cit14","first-page":"92","article-title":"Orgaran in the prevention of deep vein thrombosis in stroke patients","volume":"22","author":"Turpie","year":"1992","journal-title":"Haemostasis"},{"key":"10.1002\/14651858.CD000119.pub3-BIB14|cit15","first-page":"753","article-title":"A double blind randomized trial of Org 10172 Low Molecular Weight Heparinoid versus unfractionated heparin in the prevention of deep venous thrombosis in patients with thrombotic stroke","volume":"65","author":"Turpie","year":"1991","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD000119.pub3-BIB15|cit16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-117-5-353","article-title":"A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke","volume":"117","author":"Turpie","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000119.pub3-BIB17|cit17","first-page":"183","article-title":"Comparison of subcutaneous low-molecular heparin with intravenous standard heparin in progressive ischaemic stroke","volume":"9 Suppl 1","author":"Wong","year":"2000","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000119.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0038-1650617","article-title":"A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness","volume":"76","author":"Bergmann","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD000119.pub3-BIB19|cit19","unstructured":"Egberts JFM Sommer W Multicentre, randomised, assessor-blind, dose-comparative study of Org 10172 (Orgaran) in the treatment of acute ischaemic stroke Personal communication 1996"},{"key":"10.1002\/14651858.CD000119.pub3-BIB20|cit20","first-page":"399a","article-title":"Enoxaparin is superior to unfractionated heparin in the prevention of thromboembolic events in medical patients at increased thromboembolic risk","volume":"94 Suppl 10","author":"Harenberg","year":"1999","journal-title":"Blood"},{"key":"10.1002\/14651858.CD000119.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0049-3848(90)90422-9","article-title":"Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients","volume":"59","author":"Harenberg","year":"1990","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD000119.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0049-3848(92)90125-T","article-title":"Heparin study in internal medicine (HESIM): design and preliminary results","volume":"68","author":"Harenberg","year":"1992","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD000119.pub3-BIB23|cit23","unstructured":"McCarthy S McWalter R Durkin CJ Hallawi AH Org 10172 for the prophylaxis of deep venous thrombosis in the legs. A protocol to establish the efficacy and safety of once or twice daily subcutaneous Org 10172 injections vs placebo in 3 groups of 60 non-haemorrhagic stroke victims Unpublished protocol"},{"key":"10.1002\/14651858.CD000119.pub3-BIB24|cit24","first-page":"259","article-title":"A randomised trial of heparin therapy in acute ischemic stroke: first results","volume":"4","author":"Crepin-Leblond","year":"1994","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000119.pub3-BIB25|cit25","first-page":"153","article-title":"Applying of LMWH (clexane) and results of early rehabilitation in patients after ischemic stroke","volume":"1 Suppl 1","author":"Nikc Evic","year":"2006","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000119.pub3-BIB26|cit26","first-page":"278","article-title":"Clinical experience with heparinoid sodium pentosan polysulphate (SP54) in treatment of cerebral ischaemia","volume":"113","author":"Szirmai","year":"1986","journal-title":"Folia Haematologia Leipzig"},{"key":"10.1002\/14651858.CD000119.pub3-BIB27|cit27","unstructured":"Aventis Pharma An open-label, randomised, parallel-group, multi-centre study to evaluate the efficacy and safety of enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism in patients following acute ischaemic stroke Unpublished"},{"key":"10.1002\/14651858.CD000119.pub3-BIB28|cit28","series-title":"ASHP Midyear Clinical Meeting","first-page":"496E","article-title":"Low-molecular-weight heparin (enoxaparin) in anticoagulation transition to oral warfarin in ischaemic cerebral vascular accident (CVA) or transient ischaemic attack (TIA) patients","author":"Young","year":"2001"},{"key":"10.1002\/14651858.CD000119.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000119.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1161\/01.STR.31.7.1770","article-title":"Low-molecular weight heparins and heparinoids in acute ischemic stroke","volume":"31","author":"Bath","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000119.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"A randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000119.pub3-BIB32|cit32","first-page":"331","article-title":"Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf","volume":"17","author":"Cella","year":"1986","journal-title":"Journal of Medicine"},{"key":"10.1002\/14651858.CD000119.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-2007-1002730","article-title":"Structure and activity of heparin and its fragments: an overview","volume":"15","author":"Choay","year":"1989","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1002\/14651858.CD000119.pub3-BIB34|cit34","first-page":"19","article-title":"Fraxiparine in Ischaemic Stroke Study (FISS bis)","volume":"8","author":"Hommel","year":"1998","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000119.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00002826-199012000-00005","article-title":"Low-molecular-weight heparins and heparinoids and their use in acute or progressing ischemic stroke","volume":"13","author":"Gordon","year":"1990","journal-title":"Clinical Neuropharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000119.pub3-BIB36|cit36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000024.pub2","article-title":"Anticoagulants for acute ischaemic stroke","author":"Gubitz","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000119.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000119.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/bjs.1800840605","article-title":"Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention - update of previous meta-analyses","volume":"84","author":"Koch","year":"1997","journal-title":"British Journal of Surgery"},{"issue":"2","key":"10.1002\/14651858.CD000119.pub3-BIB39|cit39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.MR000012.pub2","article-title":"Randomisation to protect against selection bias in healthcare trials","author":"Kunz","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000119.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/bmj.305.6859.913","article-title":"Low molecular weight heparins in the prevention of perioperative thrombosis","volume":"305","author":"Leizorovicz","year":"1992","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000119.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(03)14149-9","article-title":"Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?","volume":"362","author":"Lowe","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD000119.pub3-BIB42|cit42","article-title":"Monoamine oxidase B inhibitors for early Parkinson's disease","author":"Macleod","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000119.pub3-BIB43|cit43","first-page":"186","article-title":"Experimental and clinical pharmacology of pentosan polysulphate","volume":"17 Suppl 2","author":"Maffrand","year":"1991","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1002\/14651858.CD000119.pub3-BIB44|cit44","volume-title":"Stroke: A focus of opportunity","author":"Dick","year":"1995"},{"key":"10.1002\/14651858.CD000119.pub3-BIB45|cit45","first-page":"58","article-title":"Orgaran (Org 10172): Its pharmacological profile in experimental models","volume":"22","author":"Meuleman","year":"1992","journal-title":"Haemostasis"},{"key":"10.1002\/14651858.CD000119.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0140-6736(92)93223-A","article-title":"Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis","volume":"340","author":"Nurmohamed","year":"1992","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000119.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/jnnp.56.1.17","article-title":"Antithrombotic therapy in acute stroke: an overview of the randomised trials","volume":"56","author":"Sandercock","year":"1993","journal-title":"Journal of Neurology Neurosurgery & Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000119.pub3-BIB48|cit48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000248","article-title":"Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack","author":"Sandercock","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000119.pub3-BIB49|cit49","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000029","article-title":"Antiplatelet therapy for acute ischaemic stroke","author":"Sandercock","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000119.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1378\/chest.07-1826","article-title":"Differences between low-molecular weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a meta-analysis","volume":"133","author":"Shorr","year":"2008","journal-title":"Chest"},{"key":"10.1002\/14651858.CD000119.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.279.16.1265","article-title":"Low molecular weight heparinoid ORG 10172 (Danaparoid) and outcome after acute ischemic stroke","volume":"279","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD000119.pub3-BIB52|cit52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001100.pub2","article-title":"Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism","author":"Dongen","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000119.pub3-BIB53|cit53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000119","article-title":"Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke","author":"Counsell","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000119.pub3-BIB54|cit54","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000119.pub2","article-title":"Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke","author":"Sandercock","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000119.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T00:00:00Z","timestamp":1491264000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD000119.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T20:54:22Z","timestamp":1628542462000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000119.pub3"}},"subtitle":[],"editor":[{"given":"Peter AG","family":"Sandercock","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,7,16]]},"references-count":54,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000119.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD000119.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2008,7,16]]}}}